[go: up one dir, main page]

MX2018006271A - Suplemento alimenticio y composicion para tratar sindrome metabolico. - Google Patents

Suplemento alimenticio y composicion para tratar sindrome metabolico.

Info

Publication number
MX2018006271A
MX2018006271A MX2018006271A MX2018006271A MX2018006271A MX 2018006271 A MX2018006271 A MX 2018006271A MX 2018006271 A MX2018006271 A MX 2018006271A MX 2018006271 A MX2018006271 A MX 2018006271A MX 2018006271 A MX2018006271 A MX 2018006271A
Authority
MX
Mexico
Prior art keywords
food supplement
treating
amino acids
metabolic syndrome
controlling
Prior art date
Application number
MX2018006271A
Other languages
English (en)
Inventor
Östman Elin
Björck Inger
Öste Rickard
Original Assignee
Doublegood Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Doublegood Ab filed Critical Doublegood Ab
Publication of MX2018006271A publication Critical patent/MX2018006271A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/15—Inorganic Compounds
    • A23V2250/156—Mineral combination
    • A23V2250/1586—Chromium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Tea And Coffee (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Dairy Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona un suplemento alimenticio que comprende cromo y los cinco aminoácidos leucina, isoleucina, valina, treonina y lisina, en donde la leucina, isoleucina, valina, treonina y lisina son los únicos aminoácidos presentes en el suplemento alimenticio y en donde la suma de contenido de los cinco aminoácidos es de 1.75 a 3.5 g por dosis del suplemento alimenticio, y en donde el contenido de cromo es de 4.5 a 61 µg por dosis del suplemento alimenticio. También se proporciona una composición de alimento que comprende un suplemento alimenticio así como los cinco aminoácidos para usarse en un método de tratamiento, control y prevención de enfermedades o condiciones relacionadas con el síndrome metabólico, tratamiento o control de la diabetes, tratamiento, control o prevención de obesidad, promover la saciedad, promover la pérdida de peso o promover el mantenimiento de un peso corporal sano, al disminuir la glucemia postprandial y preferiblemente también al disminuir la secreción de insulina postprandial.
MX2018006271A 2015-11-27 2016-11-28 Suplemento alimenticio y composicion para tratar sindrome metabolico. MX2018006271A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15196852 2015-11-27
PCT/EP2016/079019 WO2017089612A1 (en) 2015-11-27 2016-11-28 Food supplement and composition for treating the metabolic syndrome

Publications (1)

Publication Number Publication Date
MX2018006271A true MX2018006271A (es) 2018-11-09

Family

ID=54780108

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006271A MX2018006271A (es) 2015-11-27 2016-11-28 Suplemento alimenticio y composicion para tratar sindrome metabolico.

Country Status (11)

Country Link
US (2) US20180344677A1 (es)
EP (1) EP3379946B1 (es)
JP (2) JP7366540B2 (es)
KR (1) KR20180084069A (es)
CN (1) CN108366610A (es)
AU (1) AU2016360831B2 (es)
BR (1) BR112018010200B1 (es)
IL (1) IL259183B (es)
MX (1) MX2018006271A (es)
RU (1) RU2741637C2 (es)
WO (1) WO2017089612A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180084069A (ko) * 2015-11-27 2018-07-24 더블굳 아브 대사증후군 치료용 식품 보충제 및 조성물
IT201700087359A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201700087376A1 (it) 2017-07-28 2019-01-28 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale
IT201800006725A1 (it) 2018-06-27 2019-12-27 Composizioni comprendenti aminoacidi per l'uso nella prevenzione e nel trattamento di malattie epatiche
KR102485350B1 (ko) 2018-07-19 2023-01-06 현대자동차주식회사 저크 기반 부주의 운전 상태 판단 장치 및 방법, 그리고 차량 시스템
IT201900002109A1 (it) 2019-02-13 2020-08-13 Professional Dietetics Spa Composizioni comprendenti amminoacidi per l'uso nel trattamento di lesioni del sistema nervoso centrale
EP3998869A4 (en) * 2019-07-19 2023-09-06 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy and other uses
RU2721605C1 (ru) * 2019-11-11 2020-05-21 Общество с ограниченной ответственностью "Ай Кью Витаминная студия" Фармацевтическая композиция для парентерального капельного введения
IT202000000442A1 (it) 2020-01-13 2021-07-13 Professional Dietetics Spa Composizioni comprendenti amino acidi per l'uso nella prevenzione e nel trattamento di effetti collaterali della chemioterapia

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6831881A (en) * 1980-03-31 1981-10-08 Procter & Gamble Company, The Chromium complexes as dietary supplements and pharmaceutical agents
EP0265772B1 (en) * 1986-10-27 1992-12-23 Abbott Laboratories Liquid nutritional formula for glucose intolerance
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
JP3137273B2 (ja) * 1992-06-16 2001-02-19 明治乳業株式会社 糖尿病に有効な組成物
US5925377A (en) * 1997-08-07 1999-07-20 Nova Pharmaceutical Co. Dietary supplement composition
JP3633852B2 (ja) * 2000-06-06 2005-03-30 伶輝 程 三価クロム複合物、その乳製品およびその製造方法
CN1284297A (zh) * 2000-08-08 2001-02-21 陈凌 糖尿病患者食物添加剂
JP5126160B2 (ja) * 2001-09-26 2013-01-23 味の素株式会社 耐糖能異常用医薬組成物
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US7744930B2 (en) * 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
WO2005099483A1 (en) * 2004-04-16 2005-10-27 Indevex Ab Ingestible composition
EP1680967A1 (fr) 2005-01-14 2006-07-19 Forum Media Productions SPRL Compositions diététiques à base d'isolat de protéines solubles de lait
ES2402935T3 (es) * 2005-03-21 2013-05-10 Abbott Laboratories Composición de aminoácidos para mejorar la tolerancia a la glucosa
WO2007049818A1 (ja) * 2005-10-27 2007-05-03 Ajinomoto Co., Inc. 抗脂肪肝、抗肥満及び抗高脂血症用組成物
ES2419229T3 (es) * 2006-01-20 2013-08-20 Innova Food Ab Composición alimenticia que comprende aminoácidos
CN101632832B (zh) * 2008-07-22 2013-02-06 加特福生物科技股份有限公司 用以减少体脂肪形成的组成物及其用途
WO2012177215A1 (en) * 2011-06-23 2012-12-27 Innovafood Ab Improved food composition
RU2012126178A (ru) * 2012-06-22 2013-12-27 Малое государственное предприятие "Научно-консультационный Центр" Состав биологически активной добавки к пище
KR20180084069A (ko) * 2015-11-27 2018-07-24 더블굳 아브 대사증후군 치료용 식품 보충제 및 조성물

Also Published As

Publication number Publication date
NZ742873A (en) 2023-12-22
RU2741637C2 (ru) 2021-01-28
EP3379946B1 (en) 2024-08-21
BR112018010200A2 (pt) 2018-11-21
RU2018121404A3 (es) 2020-03-19
JP2018537974A (ja) 2018-12-27
WO2017089612A1 (en) 2017-06-01
AU2016360831B2 (en) 2021-02-18
US20230414549A1 (en) 2023-12-28
JP7366540B2 (ja) 2023-10-23
CN108366610A (zh) 2018-08-03
AU2016360831A1 (en) 2018-06-14
KR20180084069A (ko) 2018-07-24
IL259183A (en) 2018-07-31
US12161615B2 (en) 2024-12-10
JP2022008469A (ja) 2022-01-13
EP3379946A1 (en) 2018-10-03
IL259183B (en) 2021-09-30
BR112018010200B1 (pt) 2022-05-17
EP3379946C0 (en) 2024-08-21
RU2018121404A (ru) 2019-12-30
US20180344677A1 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
MX2018006271A (es) Suplemento alimenticio y composicion para tratar sindrome metabolico.
IN2014KN02830A (es)
PH12019501216A1 (en) New compounds as peptidic trigonal glp1/glucagon/gip receptor agonists
MX2016013244A (es) Derivados de exendina-4 como agonistas peptidicos duales del receptor de glp-1/glucagon.
MX2015008114A (es) Derivados de exendina-4.
MX2016013248A (es) Agonistas duales del receptor de glp-1/glucagon derivados de exendina-4.
MX2016013243A (es) Agonistas peptídicos duales de los receptores de glp-1/glucagón derivados de la exendina-4.
PH12018501969A1 (en) Pharmaceutical composition comprising empagliflozin and uses thereof
MX394909B (es) Uso de la akkermansia pasteurizada para tratar trastornos metabolicos
PH12015500531A1 (en) Glucagon analogues
MX2019006427A (es) Nuevos compuestos como agonistas peptidicos de receptores de glp1/glucagon/gip.
PH12015500688A1 (en) Exendin-4 derivatives as dual glp1/glucagon agonists
MX2018005387A (es) Variantes de fgf21.
MX2016004907A (es) Analogos del glucagon.
MX2018000362A (es) Derivados de exendina-4 como agonistas peptidicos duales selectivos de los receptores de glp-1/glucagon.
MX2017012864A (es) Analogo acilado del glucagon.
MX2019003725A (es) Glicinato de metformina, composiciones farmaceuticas que comprenden la misma, y metodos de uso de la misma.
IN2013DN10341A (es)
MX371444B (es) Metodo para inducir saciedad.
EA201400536A1 (ru) Способы получения двойных солей лоркасерина (варианты), продукты способов, двойные соли, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способ лечения и/или профилактики нарушений, связанных с ожирением
EA201301352A1 (ru) Фармацевтическая композиция и набор для профилактики и лечения нарушений, связанных с избыточным весом или ожирением, их применение и способ профилактики и лечения нарушений, связанных с избыточным весом или ожирением
EA201400308A1 (ru) Способ получения соли лоркасерина и фталевой кислоты, продукт способа, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способы лечения и/или профилактики нарушений, связанных с ожирением